January 2023 REPORT TO CONGRESS 32
prevent cost-shifting from state and local government to the Federal Government, essentially restricts
individuals in prisons and jails from utilizing Medicaid coverage. An 1115 demonstration could provide
expenditure authority for a set period of time for pre-release services, so that individuals could utilize
Medicaid coverage as they prepare to return to the community.
The advantages of an 1115 demonstration to provide coverage for a predetermined amount of time pre-
release include promoting “in-reach” into prison and jails and facilitating the establishment of
connections to community-based care prior to release. These connections may reduce gaps in care
during the reentry period, support care continuity, and support other social determinants of health such
as obtaining housing.
56
However, some stakeholders expressed concerns about allowing Medicaid
coverage pre-release. Concerns primarily centered on whether such a demonstration would incentivize
local and state criminal justice systems to keep individuals in correctional facilities, due to decreased
local and state costs of incarceration. Citing the Americans with Disabilities Act, one stakeholder stated
that incentives should be toward “provid[ing] services to people in a community-based environment,
rather than a facility.” Another stakeholder agreed that the focus should be on reforming incarceration,
not shifting health care costs.
An 1115 demonstration opportunity should also consider the length of time during which pre-release
Medicaid reimbursement for health care services is allowable. The Health and Economic Recovery
Omnibus Emergency Solutions Act or HEROES Act (H.R. 6800), passed by the U.S. House of
Representatives but not the Senate, would have allowed for Medicaid payments for health care for
incarcerated individuals during the 30-day period preceding date of release. Discussion of such an 1115
demonstration typically includes a 30-day pre-release period, but several states have applied for
demonstrations with pre-release periods longer than 30 days (see Table 1). Some stakeholders noted
that 30 days may be insufficient for coordinating and transitioning care, particularly for individuals with
SUD. If sentences are reduced, an individual may be released earlier than anticipated and without the
expected 30-day period for Medicaid coverage. Furthermore, one stakeholder expressed that “when
people are in recovery [from SUD], 30 days is a very, very small period of time.” They noted that based
on their experience providing care for individuals with OUD, a 90-day coverage period would be more
appropriate from a treatment perspective.
Demonstration design also requires consideration of the scope of covered Medicaid pre-release
benefits. As seen in Table 1, the currently submitted demonstration applications vary greatly in the
scope of pre-release benefits included in the 1115 demonstration application. Some states propose
limiting benefits to a set of services including reentry support, enhanced case management, behavioral
health services, and a 30-day medication supply. In contrast, other states propose providing the full set
of Medicaid State Plan benefits to eligible individuals.
55
Multiple stakeholders recommended that an
1115 demonstration cover the full set of benefits as well as all optional benefits, which include recovery
supports, supportive housing and employment and rehabilitation supports. Stakeholders noted the
importance of coverage for physical and behavioral health services, including crisis services. The
workgroup also discussed which population(s) should be eligible for benefits under the 1115
demonstration. Multiple stakeholders noted that many individuals enter prisons and jails with
behavioral health symptoms but without prior behavioral health diagnosis. If the demonstration limits